BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $239,000 | -9.5% | 3,078 | 0.0% | 0.03% | -3.6% |
| Q4 2021 | $264,000 | +6.5% | 3,078 | 0.0% | 0.03% | 0.0% |
| Q3 2021 | $248,000 | 0.0% | 3,078 | 0.0% | 0.03% | 0.0% |
| Q2 2021 | $248,000 | -4.6% | 3,078 | 0.0% | 0.03% | -6.7% |
| Q1 2021 | $260,000 | +1.6% | 3,078 | -3.7% | 0.03% | -3.2% |
| Q4 2020 | $256,000 | -11.4% | 3,195 | -11.0% | 0.03% | -26.2% |
| Q3 2020 | $289,000 | -37.0% | 3,590 | -32.7% | 0.04% | -41.7% |
| Q2 2020 | $459,000 | +15.0% | 5,333 | +8.5% | 0.07% | -4.0% |
| Q1 2020 | $399,000 | -3.2% | 4,913 | -0.2% | 0.08% | +19.0% |
| Q4 2019 | $412,000 | -0.5% | 4,925 | +4.1% | 0.06% | -6.0% |
| Q3 2019 | $414,000 | +7.0% | 4,730 | 0.0% | 0.07% | +8.1% |
| Q2 2019 | $387,000 | +0.5% | 4,730 | 0.0% | 0.06% | 0.0% |
| Q1 2019 | $385,000 | +23.8% | 4,730 | 0.0% | 0.06% | +10.7% |
| Q4 2018 | $311,000 | -14.8% | 4,730 | 0.0% | 0.06% | -1.8% |
| Q3 2018 | $365,000 | +4.6% | 4,730 | 0.0% | 0.06% | 0.0% |
| Q2 2018 | $349,000 | +13.3% | 4,730 | 0.0% | 0.06% | +14.0% |
| Q1 2018 | $308,000 | -10.7% | 4,730 | -11.3% | 0.05% | -3.8% |
| Q4 2017 | $345,000 | +3.0% | 5,335 | 0.0% | 0.05% | -5.5% |
| Q3 2017 | $335,000 | +358.9% | 5,335 | +342.7% | 0.06% | +243.8% |
| Q2 2017 | $73,000 | -77.4% | 1,205 | -80.7% | 0.02% | -77.8% |
| Q1 2017 | $323,000 | +26.7% | 6,235 | +8.5% | 0.07% | +60.0% |
| Q4 2016 | $255,000 | -6.9% | 5,748 | 0.0% | 0.04% | -11.8% |
| Q3 2016 | $274,000 | -10.7% | 5,748 | -15.2% | 0.05% | -13.6% |
| Q2 2016 | $307,000 | +6.2% | 6,778 | -3.8% | 0.06% | +5.4% |
| Q1 2016 | $289,000 | +8.6% | 7,046 | +1.1% | 0.06% | 0.0% |
| Q4 2015 | $266,000 | +19.8% | 6,969 | +3.3% | 0.06% | +16.7% |
| Q3 2015 | $222,000 | -53.5% | 6,748 | -1.2% | 0.05% | -46.1% |
| Q2 2015 | $477,000 | +3569.2% | 6,828 | +3631.1% | 0.09% | +4350.0% |
| Q1 2015 | $13,000 | 0.0% | 183 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $13,000 | 0.0% | 183 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $13,000 | -96.2% | 183 | -96.1% | 0.00% | -96.2% |
| Q2 2014 | $339,000 | -92.1% | 4,692 | -91.9% | 0.05% | -93.1% |
| Q1 2014 | $4,271,000 | +8.6% | 58,049 | +2.6% | 0.76% | +10.5% |
| Q4 2013 | $3,934,000 | -12.1% | 56,564 | -17.0% | 0.69% | -18.7% |
| Q3 2013 | $4,477,000 | -4.1% | 68,144 | +1.2% | 0.85% | -7.7% |
| Q2 2013 | $4,667,000 | – | 67,365 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |